Latest GlaxoSmithKline Stories
Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal
CARLSBAD, Calif., July 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
In Addition, The $105 Million Paxil Lawsuit Settlement with GlaxoSmithKline and Dozens of States, Prevents the Company From Paying Incentives to Drug Reps That Encourage Off-Label Use of Paxil
DALLAS, June 21, 2014 /PRNewswire/ -- MarketOptimizer.org offers "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam" and "CountryFocus: Healthcare,
Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited
Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical
ResolveHerpes is Designed to Boost the Body's Immune System and Allow it to Clear Out the Herpes Viruses HSV-1 and HSV-2 LOS ANGELES, June 11, 2014 /PRNewswire-iReach/ -- Resolve Herpes,
The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB)
- To swell, as grain or wood with water.